Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

'Think twice' campaign effective in reducing opioid prescribing in primary care

A campaign that urged GPs to 'think-twice' before putting a patient on opioid medicines is effective in reducing opioid prescribing in primary care, according to the findings of a major study.

5 Oct 2021

Blacks, Latinos with autoimmune diseases experience poorer outcomes due to modifiable social conditions

Minority populations in the US with multiple sclerosis and other autoimmune diseases experience poorer outcomes due to modifiable social conditions, according to a new USC study.

5 Oct 2021

Scientists use new technique to study the effects of reactive electrophilic drugs

In 2014, the European Medicines Agency approved the drug Tecfidera for the treatment of relapsing multiple sclerosis, a neurodegenerative disease that affects millions of people worldwide. In multiple sclerosis, inflammation damages the protective myelin insulation around nerves, and the nerves themselves.

30 Sep 2021

New discovery may offer a promising avenue for study of multiple sclerosis

A surprising discovery may offer a promising new direction in the study of multiple sclerosis and other diseases of hypomyelination – when axons of neurons are not covered sufficiently in fatty sheaths (myelin), which disrupts communication between nerve cells.

23 Sep 2021

The impact of multiple sclerosis therapy on COVID-19 vaccine efficacy

In a paper, the vaccine-induced cellular and immune response of MS patients receiving a range of therapies are assessed.

23 Sep 2021

Study provides clearer understanding of how migraines affect sleep patterns

Adults and children with migraines may get less quality, REM sleep time than people who don't have migraines.

23 Sep 2021

People with neurologic conditions more likely to have had adverse childhood experiences

Adults with neurologic conditions are more likely than the general population to have had adverse childhood experiences such as abuse, neglect or household dysfunction, according to a study published in the September 22, 2021, online issue of Neurology Clinical Practice, an official journal of the American Academy of Neurology.

22 Sep 2021

COVID-19 induces the generation of distinct autoantibodies

In a recent study, the association between COVID-19 and autoimmunity is investigated at all levels of disease severity.

21 Sep 2021

Light exposure during pregnancy may be linked to fetal brain development

There may be a link between exposure to light during pregnancy and fetal brain development. New findings by researchers at Umeå University, Sweden, working in collaboration with American colleagues, may provide better understanding of certain neurological diseases later in life.

20 Sep 2021

Multiple sclerosis patients elicit robust T-cell responses to mRNA COVID-19 vaccines

New research shows that Multiple Sclerosis (MS) patients undergoing anti-CD20 (aCD20) treatment – which depletes the B cells that contribute to the MS attacks – are able to mount robust T-cell responses to the mRNA COVID-19 vaccines, despite having a muted antibody response to the vaccines.

17 Sep 2021

MS patients diagnosed with colorectal cancer may have shorter survival times, study finds

People with multiple sclerosis (MS) who are diagnosed with colorectal cancer may be at a higher risk of dying from cancer or other causes over the next six months to one year than people with colorectal cancer who do not have MS, according to a study published in the September 15, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology.

16 Sep 2021

Temedica and Roche collaborate to provide digital support for multiple sclerosis patients

Munich-based digital health company Temedica and healthcare company Roche Pharma AG have announced a joint collaboration in the field of digital support for multiple sclerosis patients.

15 Sep 2021

MS patients receiving aCD20 treatment mount robust T-cell responses to COVID-19 vaccines

14 Sep 2021

Rutgers study examines link between COVID-19 and memory loss, dementia

A new Rutgers study will examine how COVID-19 is affecting individuals in a number of cognitive-related areas, including memory loss, "brain fog," and dementia.

13 Sep 2021

NIH researchers develop a detailed cellular map of chronic MS lesions

Chronic lesions with inflamed rims, or "smoldering" plaques, in the brains of people with multiple sclerosis (MS) have been linked to more aggressive and disabling forms of the disease.

10 Sep 2021

People with Parkinson's may benefit from seven categories of compensation strategies

Various strategies can help people with Parkinson's who have difficulty walking, but a new study finds that many people have never heard of or tried these strategies.

9 Sep 2021

Breakthrough discovery could pave the way for new non-opioid painkillers to treat neuropathic pain

Monash University researchers have made a breakthrough discovery that could pave the way for the development of novel non-opioid painkillers to safely and effectively treat neuropathic pain.

8 Sep 2021

Infections during adolescence linked to increased risk of developing MS later in life

According to a new study, severe infections during adolescence may lead to an increased risk of contracting MS later in life. "We're talking mainly about brain and spinal cord infections, but also respiratory tract infections," says Scott Montgomery, professor at örebro University.

8 Sep 2021

People with MS and depression have an increased risk of death, study shows

Depression is common in people with multiple sclerosis (MS), and a new study shows that people with both conditions may be more likely to die over the next decade than people with just one or neither condition.

1 Sep 2021

First pharmacological treatment option for patients with a severe form of epilepsy

Epilepsy comes in a variety of forms. Those affected by a genetically de- termined variety have severe epileptic seizures as early as the first year of life.

1 Sep 2021

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

'Think twice' campaign effective in reducing opioid prescribing in primary care

Blacks, Latinos with autoimmune diseases experience poorer outcomes due to modifiable social conditions

Scientists use new technique to study the effects of reactive electrophilic drugs

New discovery may offer a promising avenue for study of multiple sclerosis

The impact of multiple sclerosis therapy on COVID-19 vaccine efficacy

Study provides clearer understanding of how migraines affect sleep patterns

People with neurologic conditions more likely to have had adverse childhood experiences

COVID-19 induces the generation of distinct autoantibodies

Light exposure during pregnancy may be linked to fetal brain development

Multiple sclerosis patients elicit robust T-cell responses to mRNA COVID-19 vaccines

MS patients diagnosed with colorectal cancer may have shorter survival times, study finds

Temedica and Roche collaborate to provide digital support for multiple sclerosis patients

MS patients receiving aCD20 treatment mount robust T-cell responses to COVID-19 vaccines

Rutgers study examines link between COVID-19 and memory loss, dementia

NIH researchers develop a detailed cellular map of chronic MS lesions

People with Parkinson's may benefit from seven categories of compensation strategies

Breakthrough discovery could pave the way for new non-opioid painkillers to treat neuropathic pain

Infections during adolescence linked to increased risk of developing MS later in life

People with MS and depression have an increased risk of death, study shows

First pharmacological treatment option for patients with a severe form of epilepsy

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in